Free Trial
→ I'm handing you this stock today (From Behind the Markets) (Ad)tc pixel Free AQST Stock Alerts

Aquestive Therapeutics (AQST) Earnings Date, Estimates & Call Transcripts

Aquestive Therapeutics logo
$3.58 +0.07 (+1.85%)
As of 01:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Aquestive Therapeutics Earnings Summary

Aquestive Therapeutics announced Q3 2026 earnings on November 3, 2026, reporting an EPS of -$0.13, which missed analysts' consensus estimates of -$0.12 by $0.01. Quarterly revenue was reported to be $7.56 million, below analyst estimates of $11.02 million. With a trailing EPS of -$0.64, Aquestive Therapeutics' earnings are expected to decrease next year, from ($0.46) to ($0.47) per share.

Latest Q3
Earnings Date
Nov. 3Estimated
Consensus EPS
(Nov. 3)
-$0.12
Actual EPS
(Nov. 3)
-$0.13 Missed By -$0.01
Actual Revenue
(Nov. 3)
$7.56M

Q3 2026 Earnings Resources

Slide Deck

Aquestive Therapeutics' Q3 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Aquestive Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aquestive Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AQST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AQST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aquestive Therapeutics Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20262-$0.24-$0.12-$0.18
Q2 20262-$0.12-$0.11-$0.12
Q3 20262-$0.14-$0.09-$0.12
Q4 20262-$0.15-$0.09-$0.12
FY 20268-$0.65-$0.41-$0.53
Q1 20271-$0.09-$0.09-$0.09
Q2 20271-$0.10-$0.10-$0.10
Q3 20271-$0.12-$0.12-$0.12
Q4 20271-$0.10-$0.10-$0.10
FY 20274-$0.41-$0.41-$0.41

Aquestive Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026-$0.12-$0.13 -$0.01-$0.13$11.02M$7.56M
8/11/2026Q2 2026-$0.1050-$0.18 -$0.0750-$0.18$11.42M$13.82M
5/13/2026Q1 2026-$0.14-$0.07+$0.07-$0.07$10.90M$14.45M
3/4/2026Q4 2025-$0.13-$0.26 -$0.13-$0.26$13.28M$13.02M
11/5/2025Q3 2025-$0.13-$0.14 -$0.01-$0.14$12.94M$12.81M
8/11/2025Q2 2025-$0.18-$0.14+$0.04-$0.14$11.32M$10.00M
5/12/2025Q1 2025-$0.17-$0.24 -$0.07-$0.24$12.23M$8.72M
3/5/2025Q4 2024-$0.14-$0.19 -$0.05-$0.19$13.11M$11.87M

Aquestive Therapeutics Earnings - Frequently Asked Questions

Aquestive Therapeutics (NASDAQ:AQST) last announced its quarterly earning data on Tuesday, November 3, 2026. Learn more on AQST's earnings history.

In the previous quarter, Aquestive Therapeutics (NASDAQ:AQST) missed the analysts' consensus estimate of ($0.12) by $0.01 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. AQST's actual earnings.

The conference call for Aquestive Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Aquestive Therapeutics' latest earnings report can be read online.
Read Transcript

Aquestive Therapeutics (NASDAQ:AQST) has a recorded annual revenue of $48.84 million.

Aquestive Therapeutics (NASDAQ:AQST) has a recorded net income of -$83.78 million. AQST has generated -$0.64 earnings per share over the last four quarters.

Aquestive Therapeutics' earnings are expected to decrease from ($0.46) per share to ($0.47) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:AQST is sourced from Fiscal.ai, with the most recent quarter reported on 11/3/2026. New results are added as companies report their earnings.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
The Withdrawal You'll Never See on Your Statement
A proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to...
Bishop Gold Group | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel